Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03110011 5-iso PGF2a VI cPLA2i 1.0 BCD110605C28 0.189 pmol/ml medium
LMFA03110011 5-iso PGF2a VI cPLA2i 1.0 BCD110605C30 0.26 pmol/ml medium
LMFA03110011 5-iso PGF2a VI cPLA2i 1.0 BCD110605C29 0.263 pmol/ml medium
LMFA03110011 5-iso PGF2a VI cPLA2i 20.0 BCD110605C64 0.382 pmol/ml medium
LMFA03110011 5-iso PGF2a VI cPLA2i 20.0 BCD110605C66 0.335 pmol/ml medium
LMFA03110011 5-iso PGF2a VI cPLA2i 20.0 BCD110605C65 0.383 pmol/ml medium
LMFA03110011 5-iso PGF2a VI PLDi 1.0 BCD110605C16 0.235 pmol/ml medium
LMFA03110011 5-iso PGF2a VI PLDi 1.0 BCD110605C17 0.221 pmol/ml medium
LMFA03110011 5-iso PGF2a VI PLDi 1.0 BCD110605C18 0.238 pmol/ml medium
LMFA03110011 5-iso PGF2a VI PLDi 20.0 BCD110605C54 0.566 pmol/ml medium
LMFA03110011 5-iso PGF2a VI PLDi 20.0 BCD110605C52 0.563 pmol/ml medium
LMFA03110011 5-iso PGF2a VI PLDi 20.0 BCD110605C53 0.476 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+cPLA2i 1.0 BCD110605C32 0.298 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+cPLA2i 1.0 BCD110605C31 0.213 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+cPLA2i 1.0 BCD110605C33 0.268 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+cPLA2i 20.0 BCD110605C68 0.403 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+cPLA2i 20.0 BCD110605C69 0.422 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+cPLA2i 20.0 BCD110605C67 0.382 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+PLDi 1.0 BCD110605C19 0.298 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+PLDi 1.0 BCD110605C20 0.104 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+PLDi 1.0 BCD110605C21 0.364 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+PLDi 20.0 BCD110605C56 0.462 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+PLDi 20.0 BCD110605C57 0.547 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+PLDi 20.0 BCD110605C55 0.438 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+cPLA2i 1.0 BCD110605C37 0.281 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+cPLA2i 1.0 BCD110605C38 0.335 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+cPLA2i 1.0 BCD110605C39 0.287 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+cPLA2i 20.0 BCD110605C74 0.398 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+cPLA2i 20.0 BCD110605C75 0.447 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+cPLA2i 20.0 BCD110605C73 0.472 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+PLDi 1.0 BCD110605C25 0.238 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+PLDi 1.0 BCD110605C27 0.281 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+PLDi 1.0 BCD110605C26 0.263 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+PLDi 20.0 BCD110605C61 0.451 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+PLDi 20.0 BCD110605C62 0.485 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO+ATP+PLDi 20.0 BCD110605C63 0.597 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO + ATP 1.0 BCD110605C15 0.193 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO + ATP 1.0 BCD110605C14 0.085 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO + ATP 1.0 BCD110605C13 0.297 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO + ATP 20.0 BCD110605C49 0.512 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO + ATP 20.0 BCD110605C50 0.461 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO + ATP 20.0 BCD110605C51 0.471 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO 1.0 BCD110605C08 0.185 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO 1.0 BCD110605C07 0.393 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO 1.0 BCD110605C09 0.36 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO 20.0 BCD110605C45 0.464 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO 20.0 BCD110605C44 0.419 pmol/ml medium
LMFA03110011 5-iso PGF2a VI KDO 20.0 BCD110605C43 0.538 pmol/ml medium
LMFA03110011 5-iso PGF2a VI C 0.0 BCD110605C03 0.109 pmol/ml medium
LMFA03110011 5-iso PGF2a VI C 0.0 BCD110605C01 0.446 pmol/ml medium